Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

British Journal of Cancer

Volumn 91, Issue 3, 2004, Pages 525-529

  Garcia Rodriguez L A ^a   Gonzalez Perez A ^a  

^a Department of Pharmacoepidemiology   (Spain)

Author keywords

Antiinflammatory drug; Aspirin; Epidemiology; Steroids

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT;

EID: 4143114828     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602003     Document Type: Article

References (31)

1. Anderson KE, Johnson TW, Lazovich D, Folsom AR (2002) Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 94: 1168-1171
2. Chen S (1998) Aromatase and breast cancer. Front Biosci 3: d922-d933
3. Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S (1999) The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prevent Med 29: 72-76
4. Cotterchio M, Kreiger N, Sloan M, Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomark Prev 10: 1213-1217
5. Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER (1998) Over-the-counter analgesics and risk of ovarian cancer. Lancet 351: 104-107
6. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88: 988-993
7. Friis S, Nielsen GL, Mellemkjaer L, McLaughlin JK, Thulstrup AM, Blot WJ, Lipworth L, Vilstrup H, Olsen JH (2002) Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study. Int J Cancer 97: 96-101
8. García Rodríguez LA, González-Pérez A (2004) Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomark Prev 13: 649-653
9. García Rodríguez LA, Huerta-Álvarez C (2000) Reduced incidence of colorectal adenoma among long-term users of non-steroidal anti-inflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology 11: 376-381
10. García Rodríguez LA, Pérez Gutthann S (1998) Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol 45: 419-426
11. González-Pérez A, García Rodríguez LA, López-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3: 28
12. Goya L, Maiyar AC, Ge Y, Firestone GL (1993) Glucocorticoids induce a G1/ G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha. Mol Endocrinol 7: 1121-1132
13. Harris RE, Kasbari S, Farrar WB (1999) Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6: 71-73
14. Harris RE, Namboodiri KK, Farrar WB (1996) Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology 7: 203-205
15. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302: 766-768
16. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR (1997) Calcium channel blockers and risk of cancer. Lancet 349: 525-528
17. Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomark Prev 11: 1586-1591
18. Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84: 1188-1192
19. Lala PK, Al-Mutter N, Orucevic A (1997) Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer 73: 371-380
20. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, Murphy M, Vessey MP, Colin-Jones DG (1994) Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 1075-1078
21. Meier CR, Schmitz S, Jick H (2002) Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 22: 303-309
22. Neugut AI, Rosenberg DJ, Ahsan H, Jacobson JS, Wahid N, Hagan M, Rahman MI, Khan ZR, Chen L, Pablos-Mendez A, Shea S (1998) Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomark Prev 7: 869-873
23. Office for National Statistics (2002) Cancer Statistics - Registrations of Cancer diagnosed in 1998, England Series MB 1 no 29. London: The Stationery Office.
24. Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, Harris RE (1998) Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett 122: 165-175
25. Rodriguez C, Henley SJ, Calle EE, Thun MJ (1998) Paracetamol and risk of ovarian cancer mortality in a prospective study of women in the USA. Lancet 352: 1354-1355
26. Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138-146
27. Sjodahl R (2001) Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Extent, mode, and dose dependence of anticancer effects. Am J Med 110: 66S-69S
28. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266
29. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327
30. Thun MJ, Namboodiri MM, Heath CW (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596
31. Ulcickas Yood M, Rothman KJ, Johnson Ch C, Jick SS, Lang J, Wells KE, Jick H (2000) Using prescription claims data for drugs available over-the-counter (OTC). Abstract. Pharmacoepidemiol Drug Safety 9: S37